Covid-19 dan Efusi Pleura
DOI:
https://doi.org/10.62383/quwell.v1i4.994Keywords:
COVID-19, Dyspnea, Pleural EffusionAbstract
COVID-19 and pleural effusion are respiratory diseases which are currently still a matter of public concern due to their progression which can cause death if not treated quickly and appropriately. COVID-19 is a pandemic disease that was first reported to have appeared at the end of 2019. Even though the status of COVID-19 has now changed to an endemic disease, transmission is still occurring globally so it will continue. Symptoms that appear in patients with COVID-19 generally include shortness of breath, dry cough, fever and fatigue. Pleural effusion is a condition of fluid accumulation that exceeds normal limits in the pleural cavity between the parietal pleura and the visceral pleura. This fluid can be in the form of transudate or exudate fluid. This buildup of fluid can occur due to an imbalance between the production and excretion of fluid in the pleural cavity. Symptoms that arise due to pleural effusion are shortness of breath, chest pain, coughing or pleuritic chest pain. Pleural effusion is also a complication of COVID-19. There has been an increase of 404 new infections in COVID-19 in Indonesia as of January 2024 according to the latest epidemiological data, but there are no published figures for pleural effusion in Indonesia.
References
Bahar, A. (1998). Penyakit-penyakit pleura. In Soeparman, S., Sukaton U., Waspadji S., et al. (Eds.), Ilmu Penyakit Dalam (Vol. II, pp. 785-797). Balai Penerbit FKUI.
Cascella, M., Rajnik, M., Cuomo, A., Dulebohn, S. C., & Di Napoli, R. (2020). Features, evaluation, and treatment of coronavirus (COVID-19). Scientific Research Publishing. Retrieved December 3, 2024, from https://www.scirp.org/reference/ReferencesPapers.aspx?ReferenceID=2885371
Centers for Disease Control and Prevention. (2024, December 3). Symptoms of COVID-19. CDC. Retrieved from https://www.cdc.gov/covid/signs-symptoms/index.html
Clinical management of COVID-19: Interim guidance, 27 May 2020. (2020). World Health Organization. Retrieved December 3, 2024, from https://iris.who.int/handle/10665/332196
Gandhi, M., Yokoe, D. S., & Havlir, D. V. (2020). Asymptomatic transmission, the Achilles’ heel of current strategies to control COVID-19. New England Journal of Medicine, 382(22), 2158-2160. https://doi.org/10.1056/NEJMp2001899
Guo, L., Ren, L., Yang, S., et al. (2020). Profiling early humoral response to diagnose novel coronavirus disease (COVID-19). Clinical Infectious Diseases, 71(15), 778-785. https://doi.org/10.1093/cid/ciaa310
Hassan, S. A., Sheikh, F. N., Jamal, S., Ezeh, J. K., & Akhtar, A. (2020). Coronavirus (COVID-19): A review of clinical features, diagnosis, and treatment. Cureus, 12(3). https://doi.org/10.7759/cureus.7345
Huang, C., Wang, Y., Li, X., et al. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 395(10223), 497-506. https://doi.org/10.1016/S0140-6736(20)30183-5
Infeksi Emerging. (2024, January 3). Laporan harian COVID-19 per 3 Januari 2024. Retrieved from https://infeksiemerging.kemkes.go.id/document/laporan-harian-covid-19-per-3-januari-2024/view
Koehler, P., Bassetti, M., Chakrabarti, A., et al. (2021). Defining and managing COVID-19-associated pulmonary aspergillosis: The 2020 ECMM/ISHAM consensus criteria for research and clinical guidance. Lancet Infectious Diseases, 21(6), e149-e162. https://doi.org/10.1016/S1473-3099(21)00088-8
Light, R. W. (2007). Pleural diseases (5th ed.). Lippincott Williams & Wilkins.
Pusparini, P. (2020). Tes serologi dan polimerase chain reaction (PCR) untuk deteksi SARS-CoV-2/COVID-19. Jurnal Biomedika dan Kesehatan, 3(2), 46-48. https://doi.org/10.18051/jbiomedkes.2020.v3.46-48
Rita Khairani, E., Syahruddin, E., & Partakusuma, L. G. (2012). Karakteristik efusi pleura di RS Persahabatan. Jurnal Respi Indo, 32(3), 155-160.
Shen, C., Wang, Z., Zhao, F., et al. (2020). Treatment of 5 critically ill patients with COVID-19 with convalescent plasma. JAMA, 323(16), 1582-1589. https://doi.org/10.1001/jama.2020.4783
Tay, M. Z., Poh, C. M., Rénia, L., MacAry, P. A., & Ng, L. F. P. (2020). The trinity of COVID-19: Immunity, inflammation, and intervention. Nature Reviews Immunology, 20(6), 363-374. https://doi.org/10.1038/s41577-020-0311-8
World Health Organization. (2024, December 3). COVID-19 cases. WHO COVID-19 Dashboard. Retrieved from https://data.who.int/dashboards/covid19/cases
World Health Organization. (2024, December 3). Virus origin / Origins of the SARS-CoV-2 virus. WHO. Retrieved from https://www.who.int/emergencies/diseases/novel-coronavirus-2019/origins-of-the-virus
Zhu, Y., Sharma, L., & Chang, D. (2023). Pathophysiology and clinical management of coronavirus disease (COVID-19): A mini-review. Frontiers in Immunology, 14, 1116131. https://doi.org/10.3389/fimmu.2023.1116131
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Quantum Wellness : Jurnal Ilmu Kesehatan
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
